A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : GPs / glycoproteins

[Related PubMed/MEDLINE]
Total Number of Papers: 190
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   GPs  (>> Co-occurring Abbreviation)
Long Form:   glycoproteins
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 Inhibition of Arenaviruses by Combinations of Orally Available Approved Drugs. EBOV, JUNV, LASV, LCMV, MLV, PICV
2021 Subcellular localization of nucleocapsid protein of SFTSV and its assembly into the ribonucleoprotein complex with L protein and viral RNA. ERGIC, RdRp, SFTSV, vRNA
2021 The Ebola virus soluble glycoprotein contributes to viral pathogenesis by activating the MAP kinase signaling pathway. EBOV, MAPK, sGP
2020 A Bivalent, Spherical Virus-Like Particle Vaccine Enhances Breadth of Immune Responses against Pathogenic Ebola Viruses in Rhesus Macaques. ADCC, EBOV, MVA, SUDV, VLP
2020 Biomedical applications of yeasts - a patent view, part two: era of humanized yeasts and expanded applications. Abs, GI
2020 Development of an Enzyme-Linked Immunosorbent Assay to Determine the Expression Dynamics of Ebola Virus Soluble Glycoprotein during Infection. EBOV, ELISA, sGP, ssGP
2020 Differences in Tissue and Species Tropism of Reptarenavirus Species Studied by Vesicular Stomatitis Virus Pseudotypes. BIBD, VSV
2020 Modifications in the gills of hill stream Moth catfish, Hara hara (Erethistidae, Siluriformes): A light and scanning electron microscope investigation. ---
2020 Potent neutralizing monoclonal antibodies against Ebola virus isolated from vaccinated donors. EBOV
10  2020 The interplays between Crimean-Congo hemorrhagic fever virus (CCHFV) M segment-encoded accessory proteins and structural proteins promote virus assembly and infectivity. CCHFV, tc-VLP
11  2019 Enveloped viruses distinct from HBV induce dissemination of hepatitis D virus in vivo. HBV, HDV, RNP
12  2019 Estimation of serum sialic acid in oral submucous fibrosis and oral squamous cell carcinoma. OSCC, OSMF, SA
13  2019 Generation and Selection of a Panel of Pan-Filovirus Single-Chain Antibodies using Cell-Free Ribosome Display. scFvs
14  2019 Improvement of human platelet aggregation post-splenectomy with paraesophagogastric devascularization in chronic hepatitis B patients with cirrhotic hypersplenism. SPD
15  2019 Improving Baculovirus Transduction of Mammalian Cells by Incorporation of Thogotovirus Glycoproteins. AcMNPV, VSV-G
16  2019 In-depth proteomic analysis of Boleophthalmus pectinirostris skin mucus. DB
17  2019 Multipronged ESI-MS Approach for Studying Glycan-Binding Protein Interactions with Glycoproteins. AGP, alpha 2M, CAR, ESI-MS, GBPs, hGal-3C, Hp1-1
18  2019 Nix-mediated mitophagy regulates platelet activation and life span. WT
19  2018 A Critical Domain of Ebolavirus Envelope Glycoprotein Determines Glycoform and Infectivity. REBOV, ZEBOV
20  2018 A Recombinant Rabies Virus Expressing the Marburg Virus Glycoprotein Is Dependent upon Antibody-Mediated Cellular Cytotoxicity for Protection against Marburg Virus Disease in a Murine Model. ADCC, EBOV, GLA, ma-MARV, MARV
21  2018 Structural Basis of Pan-Ebolavirus Neutralization by a Human Antibody against a Conserved, yet Cryptic Epitope. ---
22  2018 Structural Basis of Pan-Ebolavirus Neutralization by an Antibody Targeting the Glycoprotein Fusion Loop. BDBV, HR1, IFL, mAbs
23  2017 Genetic Polymorphisms of Hemostatic Factors and Thrombotic Risk in Non BCR-ABL Myeloproliferative Neoplasms: A Pilot Study. FVII, MPNs, OR, SNPs, vWF
24  2017 Immunization-Elicited Broadly Protective Antibody Reveals Ebolavirus Fusion Loop as a Site of Vulnerability. bNAbs
25  2017 NRP2 and CD63 Are Host Factors for Lujo Virus Cell Entry. LUJV, NRP2
26  2017 Relative contribution of porcine reproductive and respiratory syndrome virus open reading frames 2-4 to the induction of protective immunity. ORFs
27  2017 [Molecular basis for negative-strand RNA virus entry and neutralization by antibodies]. ---
28  2016 Analysis of the entry mechanism of Crimean-Congo hemorrhagic fever virus, using a vesicular stomatitis virus pseudotyping system. BSL, CCHF, CCHFV, VSV
29  2016 Characterization of Glycoprotein-Mediated Entry of Severe Fever with Thrombocytopenia Syndrome Virus. 25-HC, DC-SIGN, DC-SIGNR, SFTS, SFTSV, SFTSV, VSV
30  2016 The roles of ebolavirus glycoproteins in viral pathogenesis. EVD, GP1,2
31  2015 Detection and identification of platelet-associated alloantibodies by a solid-phase modified antigen capture enzyme-linked immunosorbent assay method and its correlation to platelet refractoriness in multiplatelet concentrate-transfused patients. ---
32  2015 Histological and Histochemical Study of the Hepatopancreas of Two Estuarine Crab Species, Cyrtograpsus angulatus and Neohelice granulata (Grapsoidea, Varunidae): Influence of Environmental Salinity. B-cells, R-cells
33  2015 Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response. APCs, GFP, mDCs, MV, OVA, PTVs, SLAM, VSV-G
34  2015 Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein. BDBV, EBOV, EVD, mAbs, MARV, SUDV, VLPs
35  2015 Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea Pigs. EBOV, sGP
36  2015 Surface engineering of lentiviral vectors for gene transfer into gene therapy target cells. LVs, MV, VSV-G
37  2015 The glycoprotein precursor gene of Junin virus determines the virulence of the Romero strain and the attenuation of the Candid #1 strain in a representative animal model of Argentine hemorrhagic fever. AHF, GPC, JUNV, rJUNV, Rom
38  2015 The Role of Conserved N-Linked Glycans on Ebola Virus Glycoprotein 2. NGSs
39  2015 Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus. EBOV, rVSV
40  2014 An improved flow cytometric immunobead array to detect autoantibodies in plasma from patients with immune thrombocytopenic purpura. FCIA, ITP
41  2014 Analysis of determinants in filovirus glycoproteins required for tetherin antagonism. ---
42  2014 Boosting in planta production of antigens derived from the porcine reproductive and respiratory syndrome virus (PRRSV) and subsequent evaluation of their immunogenicity. GFP, PRRS, PRRSV, PRRSV, TM, TSP
43  2014 Durability of a vesicular stomatitis virus-based marburg virus vaccine in nonhuman primates. MARV, rVSV
44  2014 Establishment of reference panel for human platelet antigen genotyping. HPAs
45  2014 Safety and immunogenicity of DNA vaccines encoding Ebolavirus and Marburgvirus wild-type glycoproteins in a phase I clinical trial. WT
46  2013 A novel mechanism of immune evasion mediated by Ebola virus soluble glycoprotein. sGP
47  2013 Effects of two monoclonal antibodies, MLS128 against Tn-antigen and 1H7 against insulin-like growth factor-I receptor, on the growth of colon cancer cells. IGF-IR, mAb
48  2013 Histological and histochemical investigations of the pharyngeal jaw apparatus of a carp Cirrhinus mrigala. ---
49  2013 The intracellular cargo receptor ERGIC-53 is required for the production of infectious arenavirus, coronavirus, and filovirus particles. ER
50  2013 The lectin ERGIC-53 goes viral. ER
51  2012 Detection of autoantibodies against platelet glycoproteins in patients with immune thrombocytopenic purpura by flow cytometric immunobead array. FCIA, ITP, MAIPA
52  2012 Identification of a novel B-cell epitope of Hantaan virus glycoprotein recognized by neutralizing 3D8 monoclonal antibody. HTNV
53  2012 Membrane localization of Junin virus glycoproteins requires cholesterol and cholesterol rich membranes. JUNV
54  2012 Prediction and identification of mouse cytotoxic T lymphocyte epitopes in Ebola virus glycoproteins. EBOVs
55  2011 Determination of platelet-bound glycoprotein-specific autoantibodies by flow cytometric immunobead assay in primary immune thrombocytopenia. ITP, MAIPA
56  2011 Investigation of TNF-alpha, TGF-beta 1, IL-10, IL-6, IFN-gamma, MBL, GPIA, and IL1A gene polymorphisms in patients with idiopathic thrombocytopenic purpura. CR, ITP, SNPs
57  2011 Urinary glycosaminoglycans and glycoproteins in a calcium oxalate crystallization system. AU, CaOx, CS, GAGs, HA, HS, MSMPR
58  2010 A high-throughput biotin-avidin-ELISA for studying expression of platelet membrane glycoproteins and its clinical application. ADP, AMI, BA-ELISA, DM, ICH, mAbs, PRP
59  2010 Different potential of C-type lectin-mediated entry between Marburg virus strains. DC-SIGN, hMGL, VSV, VSV-Angola, VSV-Musoke
60  2010 Enzyme-linked immunosorbent assay for detection of filovirus species-specific antibodies. EBOV, ELISAs, MARV
61  2010 Molecular insight into human platelet antigens: structural and evolutionary conservation analyses offer new perspective to immunogenic disorders. HPAs, PLTs
62  2010 Role of Lu/BCAM glycoproteins in red cell diseases. HC, HS, RBC, SCD
63  2009 Investigation of clade B New World arenavirus tropism by using chimeric GP1 proteins. hTfR1
64  2008 Morphological and histochemical characteristics of the epithelium of ovarian lamellae of Genypterus blacodes (Schneider, 1801). ---
65  2008 Receptor determinants of zoonotic transmission of New World hemorrhagic fever arenaviruses. TfR1
66  2008 Site 1 protease is required for proteolytic processing of the glycoproteins of the South American hemorrhagic fever viruses Junin, Machupo, and Guanarito. S1P
67  2008 The mucosa of the digestive tract in Micropogonias furnieri: a light and electron microscope approach. ---
68  2008 Unique small molecule entry inhibitors of hemorrhagic fever arenaviruses. ---
69  2007 Block copolymer-oligonucleotide conjugates for genotyping on microarrays. OLISA
70  2007 Differences in tropism and pH dependence for glycoproteins from the Clade B1 arenaviruses: implications for receptor usage and pathogenicity. TCRV
71  2007 Envelope glycoproteins of hantavirus can mediate cell-cell fusion independently. HTVs, NP
72  2007 Exploring the role of cation-pi interactions in glycoproteins lipid-binding proteins and RNA-binding proteins. LBPs, RBPs
73  2007 New world clade B arenaviruses can use transferrin receptor 1 (TfR1)-dependent and -independent entry pathways, and glycoproteins from human pathogenic strains are associated with the use of TfR1. TfR1
74  2006 A pseudotype vesicular stomatitis virus containing Hantaan virus envelope glycoproteins G1 and G2 as an alternative to hantavirus vaccine in mice. VSV
75  2006 Effects of IgG and its F(ab')2 fragments of some patients with idiopathic thrombocytopenic purpura on platelet aggregation. ADP, ITP
76  2006 Histological and histochemical characterization of the mucosa of the digestive tract in flower fish (Pseudophoxinus antalyae). AB
77  2006 Histology and histochemistry of the pharyngeal cavity and oesophagus of the silverside Odontesthes bonariensis (Cuvier and Valenciennes). PAS
78  2006 Interaction profile of galectin-5 with free saccharides and mammalian glycoproteins: probing its fine specificity and the effect of naturally clustered ligand presentation. Tri-II
79  2006 Interactions of the fucose-specific Pseudomonas aeruginosa lectin, PA-IIL, with mammalian glycoconjugates bearing polyvalent Lewis(a) and ABH blood group glycotopes. ELLSA
80  2006 Patients with quinine-induced immune thrombocytopenia have both "drug-dependent" and "drug-specific" antibodies. ---
81  2006 Receptor use by pathogenic arenaviruses. alpha-DG, ES, LASV, LCMV
82  2006 Recognition profile of Morus nigra agglutinin (Morniga G) expressed by monomeric ligands, simple clusters and mammalian polyvalent glycotopes. Morniga G, Tri-II
83  2006 [Effect of anti-Helicobacter pylori ureB monoclonal antibody on platelet aggregation and activation, and its mechanism study]. HP, McAb
84  2005 Altering the tropism of lentiviral vectors through pseudotyping. VSV-G
85  2005 An experimental model for study of sialoglycoproteins of human immunodeficiency virus 1 epitope structures. CSs, HIV-1, RT, SA, SGP, SNs
86  2005 Assembly of functional hepatitis C virus glycoproteins on infectious pseudoparticles occurs intracellularly and requires concomitant incorporation of E1 and E2 glycoproteins. HCV
87  2005 Carbohydrate recognition factors of the lectin domains present in the Ricinus communis toxic protein (ricin). GalNAcalpha1-3GalNAc, F, THGP
88  2005 Differential staining of Western blots of human secreted glycoproteins from serum, milk, saliva, and seminal fluid using lectins displaying diverse sugar specificities. MPL, RSL
89  2005 Fetal-neonatal alloimmune thrombocytopenia and unexpected Glanzmann thrombasthenia carrier: report of two cases. GT, PCR, PLT
90  2005 Intracellular versus cell surface assembly of retroviral pseudotypes is determined by the cellular localization of the viral glycoprotein, its capacity to interact with Gag, and the expression of the Nef protein. MLV
91  2005 Lectinochemical studies on the glyco-recognition factors of a Tn (GalNAcalpha1-->Ser/Thr) specific lectin isolated from the seeds of Salvia sclarea. Fp, SSL
92  2005 Recognition factors of Ricinus communis agglutinin 1 (RCA(1)). Tri-II
93  2004 Cell fusion activities of Hantaan virus envelope glycoproteins. HTNV, mAbs, NP
94  2004 Evaluation of refrigerated platelet concentrates supplemented with low doses of second messenger effectors. PCs
95  2004 Kinetics of protective antibodies are determined by the viral surface antigen. NAb
96  2004 Lectinochemical studies on the affinity of Anguilla anguilla agglutinin for mammalian glycotopes. AAA, ELLSA
97  2004 Recognition profile of Bauhinia purpurea agglutinin (BPA). BPA
98  2004 Selective transduction of malignant glioma by lentiviral vectors pseudotyped with lymphocytic choriomeningitis virus glycoproteins. LCMV, VSV-G
99  2004 Surface-engineering of lentiviral vectors. MLVs
100  2003 Binding profile of Artocarpus integrifolia agglutinin (Jacalin). ELLSA, mTn